METHODS	The first group received oral therapy ( continuous conjugated equine estrogens ( CEE ) - 0.625 mg per day ) and the second group received transdermal therapy ( patches delivering continuous 17beta-estradiol ( E2 ) -- 0.05 mg per day ) .\